CCL vs DNLI · P/E 15, rev $25.02B vs $2.11B cap
Carnival Corporation (CCL) versus Denali Therapeutics Inc (DNLI) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported DNLI revenue for 2024-12-31 was $0. Net income was -$422.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. DNLI currently screens at market cap $2.11B.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. DNLI currently screens at market cap $2.11B.
Not investment advice. Open the CCL and DNLI stock pages for the full models.
Not investment advice.